Diminished zonula occludens-1 expression in the failing human heart

James G Laing1, Jeffrey E Saffitz, Thomas H Steinberg

  • 1Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. laing@id.wustl.edu

Insights

Reduced zonula occludens-1 (ZO-1) expression in heart failure disrupts connexin 43 (Cx43) gap junctions, potentially causing arrhythmias and sudden cardiac death. This study investigated ZO-1 levels in failing human hearts.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Physiology

Background:

  • Reduced expression of connexin 43 (Cx43) in heart failure is linked to arrhythmias.
  • Zonula occludens-1 (ZO-1) interacts with Cx43 and regulates gap junction formation and function.
  • The role of ZO-1 in Cx43 gap junction assembly and function in the failing heart requires investigation.

Purpose of the Study:

  • To determine if ZO-1 expression is altered in patients with heart failure.
  • To investigate the relationship between ZO-1 and Cx43 in failing human hearts.

Main Methods:

  • Immunohistochemistry was used to examine ZO-1 expression in ventricular myocardium from end-stage heart failure patients and controls.
  • Immunoblotting was performed on heart tissue lysates to quantify ZO-1 protein levels.

Main Results:

  • ZO-1 was present at 96% of intercalated discs in control hearts, colocalizing with Cx43.
  • In failing hearts, ZO-1 was found at only 5% of intercalated discs, with reduced Cx43 staining.
  • Immunoblotting revealed a 95% reduction in ZO-1 expression in human heart failure.

Conclusions:

  • Loss of ZO-1 at intercalated discs in heart failure correlates with Cx43 reduction.
  • Altered ZO-1 and Cx43 expression may lead to gap junction remodeling, abnormal impulse propagation, and arrhythmogenesis.
  • These changes likely contribute to sudden cardiac death risk in heart failure patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...